Koers Apyx Medical Corp Nasdaq
Aandelen
US03837C1062
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 49,94 mln. 46,61 mln. | Omzet 2025 * | 54,52 mln. 50,89 mln. | Marktkapitalisatie | 48,5 mln. 45,27 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -27 mln. -25,2 mln. | Nettowinst (verlies) 2025 * | -25 mln. -23,34 mln. | EV/omzet 2024 * | 0,97 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,89 x |
K/w-verhouding 2024 * |
-1,79
x | K/w-verhouding 2025 * |
-2,01
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 82,08% |
Recentste transcriptie over Apyx Medical Corp
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 15-12-17 |
Andrew Makrides
FOU | Founder | 82 | 01-01-78 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 04/12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Makrides
FOU | Founder | 82 | 01-01-78 |
Lawrence Waldman
BRD | Director/Board Member | 77 | 15-03-11 |
Craig Swandal
BRD | Director/Board Member | 63 | 09-03-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,15% | 186 mld. | |
-2,54% | 107 mld. | |
-4,43% | 67,44 mld. | |
+2,70% | 50,03 mld. | |
+16,52% | 47,81 mld. | |
+4,79% | 41,03 mld. | |
+2,76% | 26,85 mld. | |
+3,96% | 25,82 mld. | |
-0,74% | 25,01 mld. |